Announcement on Obtaining Drug Registration Certificate by Wholly-owned Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
The drug, known as the injectable form of a certain compound, is approved for production and is intended for treating peripheral artery diseases and inner ear circulation disorders.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/announcement-on-obtaining-drug-registration-certificate-by-wholly-owned-subsidiary
Announcement on Obtaining Drug Registration Certificate by Wholly-owned Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical